To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects

Pfizer

Status: Completed

Conditions: Pain

Treatments: Drug: PF-04531083

Study type: Observational

Funder types: Industry

Identifiers

NCT00992316

B1351001

Details and patient eligibility

About

The purpose of the study is to investigate the safety, toleration and pharmacokinetics of single oral doses of PF-04531083 in healthy male subjects.

Enrollment: 80 patients

Sex: Male

Ages: 21 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• young
• healthy
• male

Exclusion criteria

• elderly
• unhealthy
• female

Trial design

80 participants in 1 patient group

Pf-04531083

Description:

To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects

Treatment:

Drug: PF-04531083